Judging the therapeutic value of lymph node dissections for melanoma

Journal of the American College of Surgeons

Volumn 191, Issue 1, 2000, Pages 16-22

  Chan, Arden D ^a,b,c   Essner, Richard ^c   Wanek, Leslie A ^c   Morton, Donald L ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR VOLUME;

EID: 0033938395     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00313-6     Document Type: Article

References (50)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Silverberg E, Lubera JA. Cancer statistics, 1989. CA Cancer J Clin 1989;39:3-20.
3. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172:902-908.
4. Balch CM, Murad TM, Soong SJ, et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979;43:883-838.
5. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 5th ed. Philadelphia: Lippincott-Raven; 1998.
6. Ederer F, Axtell L, Cutler S. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-121.
7. Wanebo HJ, Woodruff J, Fortner JG. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer 1975;35:666-676.
8. Balch CM, Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979;86:343-351.
9. Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage 1) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-684.
10. Milton GW, Shaw HM, McCarthy WH, et al. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg 1982;69:108-111.
11. Reintgen DS, Cox EB, McCarty KS, Jr, et al. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983;198:379-385.
12. McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 1985;161:575-580.
13. Drepper H, Kohler CO, Bastian B, et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 1993;72:741-749.
14. Rompel R, Garbe C, Buttner P, et al. Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis. Melanoma Res 1995;5:189-194.
15. Bagley FH, Cady B, Lee A, Legg MA. Changes in clinical presentation and management of malignant melanoma. Cancer 1981;47:2126-2134.
16. Elder DE, Guerry DT, VanHorn M, et al. The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer 1985;56:413-418.
17. Karakousis CP, Kachrimanidis S, Rao U, Emrich LJ. Changes in survival with clinical stage I malignant melanoma. J Surg Oncol 1987;34:155-159.
18. Binder M, Pehamberger H, Steiner A, Wolff K. Elective regional lymph node dissection in malignant melanoma. Eur J Cancer 1990;26:871-873.
19. Crowley NJ, Seigler HF. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. Cancer 1990;66:2522-2527.
20. Slingluff CL, Jr, Stidham KR, Ricci WM, et al. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients [see comments]. Ann Surg 1994; 219:120-130.
21. Coates AS, Ingvar CI, Petersen-Schaefer K, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991 [see comments]. J Am Coll Surg 1995;180:402-429.
22. Sim FH, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 1978;41:948-956.
23. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
24. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc 1997;72:565-569.
25. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
26. Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998;351:793-796.
27. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224: 255-263; discussion 263-266.
28. Balch C, Ross M, Soong S, Harrison R. Long-term results of a prospective, randomized trial involving elective regional lymph node dissection in patients with intermediate thickness melanomas. In: Society of Surgical Oncology; March 4-7, 1999; Orlando, FL.
29. Reintgen D. The role of elective lymph node dissection in malignant melanoma: who should undergo this nodal staging procedure? J Am Coll Surg 1999;189:224-232.
30. Fortner JG, Woodruff J, Schottenfeld D, Maclean B. Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg 1977;186:101-103.
31. Bevilacqua RG, Coit DG, Rogatko A, et al. Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg 1990;212:125-131.
32. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124:1051-1055.
33. Singletary SE, Byers RM, Shallenberger R, et al. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg 1986;152:371-375.
34. Balch CM, Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-388.
35. Cohen MH, Ketcham AS, Felix EL, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;186:635-642.
36. Karakousis CP, Seddiq MK, Moore R. Prognostic value of lymph node dissection in malignant melanoma. Arch Surg 1980;115: 719-722.
37. Morton DL, Wanek L, Nizze JA, et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-499; discussion 499-501.
38. Slingluff CL, Jr, Vollmer R, Seigler HF. Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients. J Surg Oncol 1988;39:139-147.
39. Callery C, Cochran AJ, Roe DJ, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982;196:69-75.
40. Cascinelli N, Vaglini M, Nava M, et al. Prognosis of skin melanoma with regional node metastases (stage II). J Surg Oncol 1984;25:240-247.
41. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg 1991;214:627-636.
42. Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? [see comments]. Ann Surg Oncol 1999;6:263-271.
43. Day CL, Jr, Sober AJ, Lew RA, et al. Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 1981; 47:955-962.
44. Koh HK, Sober AJ, Day CL, Jr, et al. Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol 1986;4:1238-1244.
45. Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;6:442-449.
46. Morton DL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J Am Coll Surg 1999;189:214-223.
47. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958:53.
48. Cox D. Regression model and life tables. J Royal Stat Soc 1972; 346:187-220.
49. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
50. Clark WH, Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-727.